SEOUL, Nov. 17 (Korea Bizwire) – South Korea’s big three pharmaceutical ranking chart is expected to change this year as sales of Chong Kun Dang Pharmaceutical Corp. in the first three quarters beat those of Hanmi Pharmaceutical Co., the previous No. 3, their regulatory filings showed Thursday. Yuhan Co. held its leading position with 964.4 [...]
SEOUL, Oct. 31 (Korea Bizwire) – Domestic pharmaceutical firms have started to release sensitive information that may play to their disadvantage, mainly in order to eliminate any misunderstanding or speculation by not disclosing information in advance. The move is also driven by the recent Hanmi Pharmaceutical controversy, in which the company allegedly leaked insider information [...]
SEOUL, July 22 (Korea Bizwire) – Despite the blazing hot weather, pharmaceutical companies are gearing up to compete in the market for flu vaccines for the winter season, particularly tetravalent flu vaccines that are expected to hit the market this year. Tetravalent flu vaccines, which mark the next development step after trivalent flu vaccines, provide protection against [...]
SEOUL, Oct. 3 (Korea Bizwire) — Green Cross, a South Korean biopharmaceutical company, seems to surpass industry’s expectations in the global pharmaceutical market. The Seoul-based pharmaceutical company accelerates export of its not only medicines including vaccines and plasma-derivatives but also pharmaceutical plants to other countries. The volume of medicine exports accounted for 151.7 billion won, [...]